Baidu
map

盘点:2020年9月5日BMJ研究精选

2020-09-12 MedSci原创 MedSci原创

2020年9月5日BMJ研究精选

【1】接种HPV疫苗不会增加女性自主神经功能障碍综合征风险

doi: https://doi.org/10.1136/bmj.m2930

近日研究人员评估了接种4价HPV疫苗相关的自主神经功能障碍综合征风险,包括慢性疲劳综合征、复杂区域疼痛综合征和体位直立性心动过速综合征等。

本次研究为基于人群的自我对照病例研究,在丹麦开展,在2007-16年期间,参与调查的10-44岁女性参与者中,有869名患有自主神经功能障碍综合征。研究的主要终点为HPV疫苗接种与非接种人群之间自主神经功能障碍综合征发病率差异。

在10581902人随访年中,总计确诊了869名自主神经功能障碍综合征患者,其中136名为慢性疲劳综合征,535名为复杂区域疼痛综合征,198名为体位直立性心动过速综合征。在四价HPV疫苗接种后的365天内,接种人群的所有自主神经功能障碍综合征风险(比率比0.99)或特定综合征风险(慢性疲劳综合征风险比0.38;复杂区域疼痛综合征风险比1.31;体位性直立性心动过速综合征风险比0.86)未见显著增加。

【2】女性染发剂的使用与肿瘤风险评估

doi: https://doi.org/10.1136/bmj.m2942

近日研究人员评估了染发剂使用与肿瘤风险及死亡率的关系。

护士健康研究包含117200名女性参与者,基线检查时无肿瘤报告,随访36年,与从不使用染发剂的参与者相比,长期使用染发剂参与者的黑色素瘤皮肤癌以外实体癌(n=20805,危险比为0.98)或血液系统肿瘤(n=1807;1.00)的风险未见显著提高。此外,曾经使用过染发剂人群的大多数特定肿瘤(包括皮肤鳞状细胞癌、膀胱癌、黑色素瘤、雌激素受体阳性乳腺癌、孕酮受体阳性乳腺癌、激素受体阳性乳腺癌、脑癌、结直肠癌、肾癌、肺癌和大多数血液癌的主要亚类和组织学亚型)或癌症相关死亡的风险(n=4860;0.96)也未见显著提高。统计发现,曾经使用人群的基底细胞癌风险略有增加(n=22560;1.05)。值得关注的是,染发剂累积剂量与雌激素受体阴性乳腺癌、孕酮受体阴性乳腺癌、激素受体阴性乳腺癌和卵巢癌的风险增加相关。染发剂导致的特定肿瘤风险与种族相关,自然黑色发色女性染发后霍奇金淋巴瘤风险增加(70名女性患者,其中24名为自然黑发人种),而自然浅色发色人群,染发后基底细胞癌风险更高。

【3】职场性骚扰增加受害者自杀风险

doi: https://doi.org/10.1136/bmj.m2984

近日研究人员评估了职场性骚扰导致的自杀以及自杀企图风险。

本次前瞻性队列研究在瑞典开展,包含86451名从事不同职业的参与者,1995年至2013年期间接受与工作有关的性骚扰自我问卷调查,研究的主要终点为自杀和自杀企图。随访13年间,125人(0.1%)死于自杀,816人(1%)有自杀企图(比率分别为0.1和0.8/1000人随访年)。总体而言,4095名有自我报告的职场性骚扰史的参与者中有11人自杀,81110名无职场性骚扰史的参与者中有114人自杀,组间自杀企图参与者分别为61和755人。Cox回归分析中,职场性骚扰导致受害者自杀(危险比2.82)和自杀企图(1.59)风险增加,男女受害者间无显著差异。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1849096, encodeId=2a0418490965d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Nov 03 14:25:33 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909079, encodeId=7c2c9090e969, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Fri Dec 18 11:28:14 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884791, encodeId=bdc2884e91d7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/3a02391511574e11a9aa4cf69c274058/49d417ece10545679c44d78fdbb7a881.jpg, createdBy=9b335137041, createdName=索和, createdTime=Sat Sep 12 18:21:08 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884748, encodeId=0a40884e4825, content=不错,很喜欢这种盘点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Sat Sep 12 13:07:45 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884737, encodeId=7d48884e37ac, content=好文共享之, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Sep 12 11:30:37 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2020-11-03 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1849096, encodeId=2a0418490965d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Nov 03 14:25:33 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909079, encodeId=7c2c9090e969, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Fri Dec 18 11:28:14 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884791, encodeId=bdc2884e91d7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/3a02391511574e11a9aa4cf69c274058/49d417ece10545679c44d78fdbb7a881.jpg, createdBy=9b335137041, createdName=索和, createdTime=Sat Sep 12 18:21:08 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884748, encodeId=0a40884e4825, content=不错,很喜欢这种盘点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Sat Sep 12 13:07:45 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884737, encodeId=7d48884e37ac, content=好文共享之, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Sep 12 11:30:37 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2020-12-18 苏磊

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1849096, encodeId=2a0418490965d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Nov 03 14:25:33 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909079, encodeId=7c2c9090e969, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Fri Dec 18 11:28:14 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884791, encodeId=bdc2884e91d7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/3a02391511574e11a9aa4cf69c274058/49d417ece10545679c44d78fdbb7a881.jpg, createdBy=9b335137041, createdName=索和, createdTime=Sat Sep 12 18:21:08 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884748, encodeId=0a40884e4825, content=不错,很喜欢这种盘点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Sat Sep 12 13:07:45 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884737, encodeId=7d48884e37ac, content=好文共享之, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Sep 12 11:30:37 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2020-09-12 索和

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1849096, encodeId=2a0418490965d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Nov 03 14:25:33 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909079, encodeId=7c2c9090e969, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Fri Dec 18 11:28:14 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884791, encodeId=bdc2884e91d7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/3a02391511574e11a9aa4cf69c274058/49d417ece10545679c44d78fdbb7a881.jpg, createdBy=9b335137041, createdName=索和, createdTime=Sat Sep 12 18:21:08 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884748, encodeId=0a40884e4825, content=不错,很喜欢这种盘点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Sat Sep 12 13:07:45 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884737, encodeId=7d48884e37ac, content=好文共享之, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Sep 12 11:30:37 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2020-09-12 Jessica

    不错,很喜欢这种盘点!

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1849096, encodeId=2a0418490965d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Nov 03 14:25:33 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909079, encodeId=7c2c9090e969, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Fri Dec 18 11:28:14 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884791, encodeId=bdc2884e91d7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/3a02391511574e11a9aa4cf69c274058/49d417ece10545679c44d78fdbb7a881.jpg, createdBy=9b335137041, createdName=索和, createdTime=Sat Sep 12 18:21:08 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884748, encodeId=0a40884e4825, content=不错,很喜欢这种盘点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Sat Sep 12 13:07:45 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884737, encodeId=7d48884e37ac, content=好文共享之, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Sep 12 11:30:37 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2020-09-12 yangchou

    好文共享之

    0

相关资讯

盘点:2020年7月25日BMJ研究精选

2020年7月25日BMJ研究精选

盘点:2020年7月18日BMJ研究精选

2020年7月18日BMJ研究精选

盘点:2020年8月22日BMJ研究精选

2020年8月22日BMJ研究精选

盘点:2020年8月8日BMJ研究精选

2020年8月8日BMJ研究精选

盘点:2020年7月4日BMJ研究精选

2020年7月4日BMJ研究精选

盘点:2020年7月11日BMJ研究精选

2020年7月11日BMJ研究精选

Baidu
map
Baidu
map
Baidu
map